Columnar Cell Variant Thyroid Gland Papillary Carcinoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Columnar Cell Variant Thyroid Gland Papillary Carcinoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 2

NCT02973997

Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)

This phase II trial studies how well pembrolizumab and lenvatinib work in treating patients with differentiated thyroid cancer that has spread to other places i…

United States57 participantsStarted 2018-02-07

Treatment: Laboratory Biomarker Analysis, Lenvatinib